Controlling the level of a fatty acid in the brain could help treat Alzheimer's disease, a new study has claimed.
Researchers at the Gladstone Institute of Neurological Disease (GIND) and the University of California found that complete or partial removal of an enzyme that regulates fatty acid levels improves cognitive deficits in a mouse model of Alzheimer's disease (AD).
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
"Several different proteins have been implicated in Alzheimer's disease but we wanted to know more about the potential involvement of lipids and fatty acids," Nature quoted Lennart Mucke, M.D., GIND director and senior author of the study, as saying.
Fatty acids are rapidly taken up by the brain and incorporated into phospholipids, a class of fats that form the membrane or barrier that shields the content of cells from the external environment.
![Dyslexia]( "Dyslexia")
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.
The researchers used a large scale profiling approach to compare many different fatty acids in the brains of normal mice with those in a mouse model of Alzheimer's disease that develops memory deficits and many pathological alterations seen in the human condition.
"The most striking change we discovered in the Alzheimer mice was an increase in arachidonic acid and related metabolites in the hippocampus, a memory center that is affected early and severely by Alzheimer's disease," said Rene Sanchez-Mejia, M.D., lead author of the study.
In the brain, arachidonic acid is released from phospholipids by an enzyme called group IVA phospholipase A2 (or PLA2).
The researchers lowered PLA2 levels in the Alzheimer mice by genetic engineering. They found that removal or even partial reduction of PLA2 prevented memory deficits and other behavioral abnormalities in the Alzheimer mice.
"Arachidonic acid likely wreaks havoc in the Alzheimer mice by causing too much excitation, which makes neurons sick. By lowering arachidonic acid levels, we are allowing neurons to function normally," said Sanchez-Mejia.
"In general, fatty acid levels can be regulated by diet or drugs. Our results have important therapeutic implications because they suggest that inhibition of PLA2 activity might help prevent neurological impairments in Alzheimer's disease. But a lot more work needs to be done before this novel therapeutic strategy can be tested in humans," Sanchez-Mejia added.
The study is published in the issue of Nature Neuroscience.
Source: ANI
RAS/SK
Dyslexia
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.
Advertisement
The researchers used a large scale profiling approach to compare many different fatty acids in the brains of normal mice with those in a mouse model of Alzheimer's disease that develops memory deficits and many pathological alterations seen in the human condition.
"The most striking change we discovered in the Alzheimer mice was an increase in arachidonic acid and related metabolites in the hippocampus, a memory center that is affected early and severely by Alzheimer's disease," said Rene Sanchez-Mejia, M.D., lead author of the study.
In the brain, arachidonic acid is released from phospholipids by an enzyme called group IVA phospholipase A2 (or PLA2).
The researchers lowered PLA2 levels in the Alzheimer mice by genetic engineering. They found that removal or even partial reduction of PLA2 prevented memory deficits and other behavioral abnormalities in the Alzheimer mice.
"Arachidonic acid likely wreaks havoc in the Alzheimer mice by causing too much excitation, which makes neurons sick. By lowering arachidonic acid levels, we are allowing neurons to function normally," said Sanchez-Mejia.
"In general, fatty acid levels can be regulated by diet or drugs. Our results have important therapeutic implications because they suggest that inhibition of PLA2 activity might help prevent neurological impairments in Alzheimer's disease. But a lot more work needs to be done before this novel therapeutic strategy can be tested in humans," Sanchez-Mejia added.
The study is published in the issue of Nature Neuroscience.
Source: ANI
RAS/SK
Brain Depression - Animation
Interactive section of Medindia provides information about chemistry of Brain depression
Advertisement
 Smoking may Cause Cognitive DeclineStudying a population of 1,964 men and women in the Netherlands, a team of researchers has found that people who smoke are more likely to be poorer than those who do not in terms of | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Tobacco smoke contains toxic chemicals which damage lungs, weaken the immune system and cause tuberculosis.
Identifying an unappreciated relationship between brain shape and activity overturns the century-old paradigm emphasizing the importance of complex brain connectivity.
Decoding the eight factors affecting Black adults' life expectancy.
Sobering truth about foot travel in the United States emerges from international statistics, highlighting the prevalence of walking on the Blacksburg campus.
Unveiling a hidden mechanism, proteins within brain cells exhibit newfound abilities at synapses, reinforcing Darwin's theory of adaptation and diversity in the natural world.